NMPA Approval

Mirvetuximab Soravtansine Injection

Approval Number

国药准字SJ20240044

Registration Date

November 22, 2024

Drug Information

Generic Name

索米妥昔单抗注射液

Trade Name

爱拉赫

Dosage Form

注射剂

Strength

100mg（20ml）/瓶

Drug Type

生物制品

Registration Date

November 22, 2024

Expiry Date

November 21, 2026

Company Address

830 Winter Street, Waltham, MA 02451, USA

Company Address

Via Appia KM 65,561, Latina Scalo, Latina 04013, Italy

Empowering clinical research with data-driven insights and AI-powered tools.